Calendrier des promotions Mainz Biomed N.V.
Calendrier avancé
Graphique simple
À propos de l'entreprise Mainz Biomed N.V.
Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.IPO date | 2021-11-05 |
---|---|
ISIN | NL0015000LC2 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://mainzbiomed.com |
Цена ао | 5.68 |
Changement de prix par jour: | -13.41% (6.04) |
---|---|
Changement de prix par semaine: | -8.89% (5.74) |
Changement de prix par mois: | +3.56% (5.05) |
Changement de prix sur 3 mois: | +2 277.27% (0.22) |
Changement de prix sur six mois: | +1 234.18% (0.392) |
Changement de prix par an: | +461.76% (0.931) |
Evolution du prix sur 3 ans: | -64.47% (14.72) |
Evolution du prix sur 5 ans: | -0% (5.23) |
Evolution des prix sur 10 ans: | -0% (5.23) |
Evolution des prix depuis le début de l'année: | +8.51% (4.82) |
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
Établissements | Volume | Partager, % |
---|---|---|
Prelude Capital Management LLC | 75000 | 0.43 |
Citadel Advisors Llc | 33244 | 0.19 |
Northern Trust Corporation | 33082 | 0.19 |
Morgan Stanley | 32045 | 0.18 |
Geode Capital Management, LLC | 15189 | 0.09 |
Vontobel Holding Limited | 14000 | 0.08 |
XTX Topco Ltd | 13850 | 0.08 |
Greenwich Investment Management, Inc. | 13784 | 0.08 |
NewEdge Advisors, LLC | 1000 | 0.01 |
Citigroup Inc. | 673 | 0 |
Superviseur | Titre d'emploi | Paiement | Année de naissance |
---|---|---|---|
Mr. Guido Baechler | CEO & Executive Director | N/A | 1965 (60 années) |
Mr. William J. Caragol | Chief Financial Officer | N/A | 1967 (58 années) |
Dr. Frank Krieg-Schneider | Chief Technology Officer | N/A | 1962 (63 année) |
Dr. Moritz Eidens Ph.D. | Chief Science Officer & Executive Director | N/A | 1984 (41 année) |
Stefan Erlach | Head of Human Resources | N/A | |
Mr. Philipp Freese | Chief Business Officer | N/A | 1983 (42 année) |
Dr. Christopher Von Torne P.M.P., Ph.D. | Chief Operating Officer | N/A | 1972 (53 année) |
Adresse: Germany, Mainz, Robert Koch Strasse 50 - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://mainzbiomed.com
Site web: https://mainzbiomed.com